Gallstone pancreatitis should not be considered a contraindication to GLP-1/GIP therapy after cholecystectomy, though a history of recent pancreatitis should give one pause in prescribing a GLP-1/GIP agonist
Due to the lack of adverse effects, N-acetylcysteine can be regarded as an appropriate substitute for insulin-reducing medication in PCOS treatment
Colon sections were scored based on four parameters: epithelial damage (03), crypt damage (03), goblet cell depletion (03), and inflammatory cell infiltration (03), and the average score of each parameter was calculated
However, GLP-1 drugs may serve as a valuable complement, adding another layer of support for those struggling with cravings and dysregulated reward pathways, making them worthy of more research and consideration
Triple Agonism Triple agonism adds a third receptor component and creates a different integrated signaling profile